Tci Wealth Advisors, Inc. Provention Bio, Inc. Transaction History

Tci Wealth Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$6.7 - $24.21 $730 - $2,638	109 Added 27.25%	509 $12,000
Q1 2022 Apr 29, 2022	SELL	$3.4 - $7.88 $2,346 - $5,437	-690 Reduced 63.3%	400 $3,000
Q4 2021 Jan 24, 2022	BUY	$5.59 - $7.39 $3,857 - $5,099	690 Added 172.5%	1,090 $6,000
Q3 2021 Oct 29, 2021	SELL	$5.66 - $8.33 $2,626 - $3,865	-464 Reduced 53.7%	400 $3,000
Q2 2021 Aug 02, 2021	SELL	$6.71 - $11.04 $1,583 - $2,605	-236 Reduced 21.45%	864 $7,000
Q1 2021 Apr 29, 2021	BUY	$10.12 - $19.45 $1,011 - $1,945	100 Added 10.0%	1,100 $12,000
Q3 2020 Oct 20, 2020	BUY	$10.34 - $15.2 $2,068 - $3,040	200 Added 25.0%	1,000 $13,000
Q1 2020 Apr 14, 2020	SELL	$5.42 - $17.75 $1,084 - $3,550	-200 Reduced 20.0%	800 $7,000
Q4 2019 Jan 27, 2020	BUY	$5.84 - $14.9 $1,168 - $2,980	200 Added 25.0%	1,000 $15,000
Q3 2019 Oct 17, 2019	BUY	$6.83 - $13.0 $4,781 - $9,100	700 Added 700.0%	800 $5,000
Q2 2019 Jul 23, 2019	BUY	$2.3 - $13.79 $229 - $1,379	100 New	100 $1,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.